Canakinumab
Definition: Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including adult-onset Still's disease, gout flares. It is a human monoclonal antibody targeted at interleukin-1 beta. source: Wikipedia
- ID
- 698091001
- ID date
- 15 Oct 2014
- Previous ID
- 16111411000001107
- Name
- Canakinumab